Published on:

Judge Andrews recently found the asserted claims of one asserted patent invalid for obvious-type double patenting after a four day trial on three asserted patents. Novartis Pharmaceuticals Corp. v. Breckenridge Pharmaceutical, Inc., et al., C.A. Nos. 14-1043-RGA, 14-1196-RGA, and 14-1289-RGA (D. Del. Apr. 3, 2017).  The Court found that the earlier-expiring post-URAA patent (the ‘990 patent) could serve as a double patenting reference for a later-expiring pre-URAA patent (the asserted ‘772 patent), relying on the BPIA decision in Ex Parte Pfizer, Inc. Patent Owner & Applicant, 2010 WL 532133, at *6 (Bd. Pat. App. & Interf. Feb. 12, 2010) (cited in Gilead Sciences, Inc. v. Natco Pharma Ltd., 753 F.3d 1208, 1212 (Fed. Cir. 2014)), as well as several other district court decisions.  Judge Andrews found that the defendants failed to meet their burden to invalidate the other two asserted patents, which the plaintiffs proved were infringed.

Novartis Pharma Corp. v. Breckenridge Pharma Inc., C.A. No. 14-1043-RGA (D. Del. Mar. 30, 2017)

Published on:

Senior Judge Sue L. Robinson recently considered the parties’ summary judgment motions in Quest Integrity USA, LLC v. Clean Harbors Industrial Services, Inc., et al., No. 14-1482-SLR, 14-1483-SLR (D. Del. Mar. 28, 2017).  Judge Robinson granted defendants’ motion for summary judgment that claims 1, 11, 12, 13, 24, 25, 27, 28, 30, 33, and 37 of U.S. Patent No. 7,542,874 are invalid as anticipated under 35 U.S.C. § 102(b) based on plaintiff’s sale to Orion Norco Refining.  Id. at 8-42.  Judge Robinson also granted defendant Clean Harbors’ motion for summary judgment of non-infringement; and granted-in-part defendant Cokebusters’ motion for summary judgment of non-infringement.  Judge Robinson denied the remaining motions.  Id. at 47-48.

Quest 14-1482

UPDATE:  On April 7, 2017, Judge Robinson considered defendant’s limited motion to reconsider denial of defendant’s summary judgment motion of invalidity as to one claim (the Court previously granted summary judgment as to the other claims of the patent-in-suit).  Quest Integrity USA, LLC v. Cokebusters USA Inc., No. 14-1483-SLR (D. Del. Apr. 7, 2017).  Judge Robinson granted the motion, invalidating claim 40 as anticipated by the Norco sale under 35 U.S.C. § 102(b).

Published on:

In Mitchell Ellis Products, Inc. v. Agrinomix LLC, C. A. No. 16-367-SLR (D. Del. Mar. 16, 2017), Judge Sue L. Robinson granted a motion to transfer of a defendant that, while a Delaware company, only had operations and advertisement in Ohio and had not sold any accused products in Delaware.  The Court, as in other opinions, found the location of potential witnesses and books and records, as well as court congestion, to be neutral factors in the Jumara analysis, and observed that transfer would often be denied where a defendant was a Delaware company and did “business on a national scale, including Delaware.” Id. at 3-4.  Here, based on the averment of Defendant’s Managing Member and President, the latter factor was not present: “[t]here is no evidence of record — despite the intervening discovery and further briefing on this and related motion — that [Defendant] has sold or even advertised the accused devices in Delaware. Transfer of the above-captioned case to the United States District Court for the Northern District of Ohio, therefore, is appropriate.” Id. at 4.

Mitchell Ellis Products, Inc. v. Agrinomix LLC, C. A. No. 16-367-SLR (D. Del. Mar. 16, 2017)

Published on:

In a recent Report and Recommendation, Chief Magistrate Judge Mary P. Thynge granted defendants’ renewed motion for attorneys’ fees. Magnetar Technologies, Corp. v. Six Flags Theme Parks, Inc., C.A. No. 07-127-LPS-MPT (D. Del. Mar. 13, 2017). Previously, on July 21, 2015, Judge Thynge issued a Report and Recommendation finding that, in view of the totality of the circumstances, the case was exceptional based on plaintiffs’ objectively unreasonable position on inventorship of U.S. Patent No.  5,277,125 (“the ‘125 patent”) and plaintiffs’ reliance on Mark T. Hanlon’s expert report with respect to infringement of the ‘125 patent. On September 30, 2015, having considered plaintiffs’ objections to that Report and Recommendation and defendants’ subsequent response, Chief Judge Leonard P. Stark returned the issue of attorneys’ fees to Judge Thynge for additional findings.  On November 31, 2015, defendants filed the instant renewed motion for attorneys’ fees. See id. at 6.

In granting the renewed motion, Judge Thynge first reaffirmed the court’s conclusion “that plaintiffs’ position on the issue of inventorship was objectively unreasonable and defendants are entitled to fees incurred following the depositions in late July 2011” that demonstrated incorrect inventorship. Id. at 17-18. Judge Thynge also reaffirmed the court’s conclusion that plaintiffs’ reliance on Hanlon’s expert report was objectively unreasonable. Id. at 19.

Judge Thynge further found that attorneys’ fees in this action were “warranted to deter parties from continuing to maintain claims based on objectively unreasonable positions,” and “to compensate the defendants in this case for the expenses in defending claims that should not have been maintained.” Id. at 29. As Judge Thynge explained, “[p]laintiffs’ continued litigation of the ‘125 patent after the Chung and Staehs depositions revealed the inventorship issue with that patent improperly increased defendants’ litigation expenses by forcing them to continue to defend against the infringement claim and pursuing a ruling that the patent was invalid.” Id. at 29-30.

Published on:

Judge Gregory M. Sleet recently considered defendants’ motion to stay pending inter partes review of one patent in suit.  f’Real Foods, LLC v. Hamilton Beach Brands, Inc., No. 16-41-GMS (D. Del. Mar. 9, 2017).  Judge Sleet denied the motion, finding that the plaintiff would suffer undue prejudice and because the litigation at issue “will be minimally simplified.”  Id. at 2.  Judge Sleet importantly noted that the parties are direct competitors and that the Patent Trial and Appeal Board instituted inter partes review on only one claim of one of the patents in suit.  Id. at 2, n.3.  Further, there were many issues in the litigation  that would not be impacted by the inter partes review, namely “the litigation of the two patents-in-suit for which Defendants have not sought IPR, trademark infringement issues, and Defendants inequitable conduct and antitrust counterclaims.”  Id. at 3, n.4 (internal quotations omitted).

f’Real Foods, LLC v. Hamilton Beach Brands, Inc., No. 16-41-GMS (D. Del. Mar. 9, 2017)

Published on:

Judge Richard G. Andrews recently denied a motion for judgment on the pleadings that the plaintiff’s volume control patents and pairing patents claimed unpatentable subject matter under 35 U.S.C. § 101.  Sonos, Inc. v. D&M Holdings Inc., C.A. No. 14-1330-RGA (D. Del. Mar. 13, 2017).  The defendants argued that the “Volume patents are directed to the abstract idea of ‘controlling audio settings for multiple audio devices,'” a “very basic” concept.  Id. at 8.  Judge Andrews disagreed, though, and explained that “the invention as claimed in each of the Volume patents represents a substantial improvement over the existing technology – the invention described in the patents allows for the audio devices to be grouped and regrouped in real time simply using a user interface to select the desired members of the groups without the need for altering any hard wiring in the physical system.  This is not simply a ‘more efficient’ method of doing something already done by humans.  It is a method that provides for capabilities far beyond what a traditional hardwired system offers.”  Id. at 12.   The Court also rejected the argument that the pairing patents were no more than an abstract idea, explaining “the Pairing patents claim methods that involve specific devices (playback devices and controllers) that are described in the specification.”  Id. at 15.  Further, “the claimed methods do not simply represent an automation of something done manually. . . . This simply is not the kind of method that could be performed manually, and, even if it were, automating the method as claimed represents a substantial improvement to the functionality of the specific device.”  Id.

Continue reading

Published on:

In Boston Scientific Corporation, et al. v. Edwards Lifesciences Corporation, C.A. No. 16-275-SLR-SRF (D. Del. Feb. 28, 2017), Magistrate Judge Sherry R. Fallon granted defendant and counterclaim/third-party plaintiff (collectively, “Edwards”)’s motion for leave to amend their answer to add a prior use defense pursuant to 35 U.S.C. § 273.

Evaluating the proposed amendment under Rule 15, the Court concluded that the proposed affirmative defense was “factually sufficient” for this stage of the proceedings, where Plaintiffs had not pointed to any authority requiring a heightened pleading standard for affirmative defenses – rather, affirmative defenses are not held to the same pleading standard as claims or counterclaims. Id. at 3-4.  The Court also held that the new defense would not cause undue delay where the motion was filed prior to the case’s deadline for amendment of pleadings and where the case was in its early stages, with fact discovery closing in spring 2017. Id. at 4.  As to prejudice, although Plaintiffs “claim[] that [they] did not anticipate the addition of Edwards’ prior use defense when [they] negotiated the discovery limits in the scheduling order, [Plaintiffs] acknowledged the possibility of an amended answer by stipulating to the deadline for amended pleadings in the scheduling order at the time of discovery negotiations.” Id. at 5.

However, “[t]o the extent [Plaintiffs] would be prejudiced by the need to obtain additional discovery directed to the prior use defense, a limited grant of additional discovery [was] warranted.” Id. Accordingly, the Court granted Plaintiffs’ request for an increase in their limits on discovery requests and an extension to serve new document requests, but did not provide Plaintiffs with the full requested increase, as “[i]n view of the unused requests available to [Plaintiffs] under the scheduling order . . . the number of additional requests sought by [Plaintiffs] is unnecessary.” Id. at 6.

Published on:

In this case, Plaintiff T-Jat systems alleged in its operative complaint that the three Defendants, Expedia, Inc. (Delaware), Expedia, Inc. (Washington), and Orbitz Worldwide Inc. “operate as a single entity” with a high degree of intermingling. T-Jat Systems 2006 Ltd. v. Expedia, Inc., et al., C.A. No. 16-581-RGA-MPT, Report and Recommendation at 1-3 (D. Del. Mar. 7, 2017). In response to this allegation, the Defendants moved to dismiss, arguing that “the first amended complaint fails to satisfy the pleading requirements of FED. R. CIV. P. 8(a) because it does not set forth facts sufficient for a facially plausible claim from which the court can infer the alleged misconduct . . . [particularly because] T-Jat’s allegations that Expedia-DE and Expedia-WA acted as one entity because of the companies’ parent-subsidiary relationship [is] far fetched, and the first amended complaint fails to show ‘facts that justify piercing the corporate veil.’” Id. at 5.

Magistrate Judge Thynge first rejected Plaintiff’s alter-ego theory, finding that “T-Jat has, at best, alleged sufficient facts to establish . . . a failure to observe corporate formalities and subsidiary companies acting as a façade for the parent companies” but not additional factors that would help prove a true alter-ego relationship. Plaintiff alleged sharing of certain officers and directors, sharing of a headquarters and offices, and a collective identify on marketing and promotional materials. “However, T-Jat does not allege the second element of fraud or injustice of use of the corporate form in either case. Recent case law from this court establishes that factual allegations of ‘nothing more than a close relationship and coordination among defendants,’ including operational control of the parent company over subsidiaries, is insufficient under Rule 12(b)(6). As such, the alter-ego theory against all three defendants is inadequate to meet the minimum pleading requirements.” Id. at 9-12.

Judge Thynge refused to dismiss, however, Plaintiff’s agency theory, explaining that “[o]ne can reasonably infer Expedia-DE’s control over Expedia-WA and Expedia’s control over Orbitz from the alleged facts. Further, the court can reasonably deduce Expedia-DE directed Expedia-WA’s actions, and likewise Expedia directed Orbitz’s activities relating to the underlying cause of action, the allegedly infringing mobile and website applications, based on the close connection between the respective companies. Although this corporate closeness may not be sufficient to succeed on agency theory at later stages in litigation, it is sufficient to survive a motion to dismiss, if the parties are properly and individually identified.” Id. at 12-13.

Finally, Judge Thynge agreed with Defendants that the complaint improperly conflated separate entities into a generic “Defendants” rather than pleading sufficient facts against each individual Defendant: “Although T-Jat’s assertions of Orbitz’s individual infringement may be facially plausible, the allegations as to Expedia-DE and Expedia-WA do not clarify that each defendant committed at least one infringing act. Therefore, the first amended complaint fails to provide Defendants with adequate notice of the direct infringement allegations against them and fails to meet the minimum pleadings standard.” Id. at 14-15.

Continue reading

Published on:

On January 23, 2017, Magistrate Judge Christopher J. Burke issued a standing order regarding courtroom opportunities for newer attorneys. The standing order explains that “[t]he Court is cognizant of a growing trend in which fewer cases go to trial, and in which there are generally fewer opportunities in court for speaking or ‘stand-up’ engagements. This is especially true for newer attorneys, that is, attorneys practicing for less than seven years (‘newer attorney(s )’).” Id. at 1. The standing order goes on:  “Recognizing the importance of the development of future generations of practitioners through courtroom opportunities, the undersigned Judge encourages the participation of newer attorneys in proceedings in my courtroom—particularly as to oral argument on motions where the newer attorney drafted or contributed significantly to the briefing for the motion.”

Accordingly, Judge Burke adopted the following procedures regarding oral argument as to pending motions:

  1. After a motion is fully briefed, either as part of a Request for Oral Argument, or in a separate Notice filed thereafter, a party may alert the Court that, if argument is granted, it intends to have a newer attorney argue the motion (or a portion of the motion).
Published on:

In a recent Memorandum Order, Magistrate Judge Christopher J. Burke denied plaintiffs’ (“Integra”) motion for leave to file an amended complaint, concluding that “to grant the Motion would cause substantial and undue prejudice to Defendant.” Integra LifeSciences Corp. v. Hyperbranch Medical Technology, Inc., C.A. No. 15-819-LPS-CJB (D. Del. Feb. 16, 2017). First, Judge Burke observed that the parties and Court have “spent substantial time and effort attempting to address and narrow the issues in what is already a large, complex matter.” Id. at 2.  As Judge Burke explained, the action is a “six-patent case” and one patent “involves complicated chemical technologies.” Id. Judge Burke further explained that the “parties . . . proceeded through a lengthy and involved preliminary injunction phase,” and since then, they “have expended more time on discovery (and on discovery disputes), have narrowed the number of claims and references at issue, and are currently in the midst of claim construction briefing (involving 20 disputed claim terms).” Id.

Second, Judge Burke found that the additions in the proposed Amended Complaint, which sought to add two new patents, “are not minor.” Id. While Judge Burke acknowledged that there is some overlap between the operative complaint and proposed Amended Complaint, he observed that the new patents had different inventors and implicated embodiments not directly at issue with the original patents. Id. at 2-3. Judge Burke further observed that defendant “is  . . . understandably concerned with how a jury will be able to grasp its arguments at trial, were a case as large as this to become ever larger after amendment.” Id. at 3.

Third, Judge Burke found that “were the Motion granted, this would surely do violence to the current case schedule.” Id. Judge Burke explained that “the addition of the new patents will no doubt necessitate significant additional fact and expert discovery, claim construction and discovery dispute proceedings, and dispositive motion practice.” Id. Further, “[t]he current trial date would surely be lost, and the case schedule would no doubt need to be pushed back by many months (at least).” Id.

Contact Information